Sun, Aug 18 9:05am

Compare REGN

Regeneron Pharmaceuticals Inc [REGN]
$296.85 3.74 (1.28%)

REGN Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 32.60 Billion
REGN Description

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has six marketed products: Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Zaltrap in colorectal cancer; Dupixent in atopic dermatitis and asthma; Libtayo in cutaneous squamous cell carcinoma; Arcalyst in CAPS; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer.

Visit Website

REGN Earnings

EPS 1.77 P/E Ratio 24.20
Previous Earnings Tue, May 7, 2019
Latest Earnings Tue, Aug 6, 2019 (12 days ago) -0.91%

REGN Dividend

Yield --
Ex-Date --
Pay Date --
History --

REGN Charts

1 Year
Jul 11, 2019
Mar 1, 2019

Symbol Price Day % YTD %
REGN $296.85 1.28% -20.30%

Symbol Surfing

How can we make Symbol Surfing better?

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy